Education, Science, Technology, Innovation and Life
Open Access
Sign In

Analysis of Financial Statements in the Context of PEST ——Taking Shanghai Jiahua as an Accounting Example

Download as PDF

DOI: 10.23977/acccm.2023.050203 | Downloads: 77 | Views: 690

Author(s)

Chen Jinhao 1, Dou Meitao 1, Sun Haozhi 1, Jin Chunmiao 1, Liu Liangbin 1

Affiliation(s)

1 Department of Finance and Economics, Shandong University of Science and Technology, Jinan, Shandong, 250031, China

Corresponding Author

Chen Jinhao

ABSTRACT

With the improvement of the living standard of Chinese residents and the formation of consumers' daily cosmetics consumption habits, the market size of China's cosmetics industry is growing constantly, promoting the accelerated development of the domestic cosmetics industry. The future market space is broad, which is both an opportunity and a challenge for the development of China's cosmetics industry. This paper selects Shanghai Jiahua as the case object. Based on the existing relevant theories, first of all, the PEST analysis method is used to make a detailed analysis of the industry environment of the current macro environment in which Shanghai Jiahua is located. Secondly, the financial analysis of Shanghai Jiahua is carried out from four aspects of the company's debt paying ability, operating ability, profitability, and development ability.

KEYWORDS

PEST Analysis, Financial Statement Analysis, Business Management, Beauty Industry

CITE THIS PAPER

Chen Jinhao, Dou Meitao, Sun Haozhi, Jin Chunmiao, Liu Liangbin, Analysis of Financial Statements in the Context of PEST ——Taking Shanghai Jiahua as an Accounting Example. Accounting and Corporate Management (2023) Vol. 5: 17-23. DOI: http://dx.doi.org/10.23977/acccm.2023.050203.

REFERENCES

[1] Li Qian, Xu Chaoyang. Financial Analysis of Listed Companies——Take G Company in the Pharmaceutical Industry as an Example. China Business Theory, 2020(22):52-55.
[2] Wang Ying. Financial Risk Prevention of Pharmaceutical Enterprises Based on Internal Control Perspective. Fortune Times, 2020(11):72-73.
[3] White K.L.; Williams T.F.; Greenberg B.G. The ecology of medical care. Bull. New York Acad. Med. 1996, 73, 187.
[4] Duwe E.A.G. Toward a Story Powerful Enough to Reduce Health Inequities in Indian Country: The Case of Diabetes. Qual. Inq. 2016, 22, 624–635.
[5] Varvasovszky Z.; Brugha R. Stakeholder analysis: A review. Health Policy Plan. 2000, 15, 239–246.
[6] Eakin M.J. Educating Critical Qualitative Health Researchers in the Land of the Randomized Controlled Trial. Qual. Inq. 2016, 22, 107–118.
[7] Strauss A.; Corbin J. Basics of Qualitative Research: Grounded Theory Procedures and Techniques; Sage: London, UK, 1990.
[8] Mainardes E.W.; Raposo M.; Alves H. Organizations with dispersed powers: Suggestion of a new management model based on the stakeholders theory. J. Manag. Res. 2011, 3, 1–31.
[9] Reiter V. The Pattern of Relationship between Trust and Collaboration amongst Non-Profit Organizations and Health Funds; University of Haifa Press: Haifa, Israel, 2010.
[10] Severin F.; Borry P.; Cornel M.C.; Daniels N.; Fellmann F.; Hodgson S.V.; Howard H.; John J.; Kaariainen H.; Kayserili H.; et al. Points to consider for prioritizing clinical genetic testing services: A European consensus process oriented at accountability for reasonableness. Eur. J. Hum. Genet. 2015, 23, 729–735.

Downloads: 15501
Visits: 193913

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.